Navigation Links
BioMedix™ Announces John Martin, MD, FACS, as Medical Director
Date:6/16/2011

SAINT PAUL, Minn., June 16, 2011 /PRNewswire/ -- BioMedix™, a health IT company focused on improving lives through integrated medical devices and software, announces the appointment of John Martin, MD, FACS, as Medical Director. A respected researcher and author, Dr. Martin is one of the only board certified Vascular Surgeons in the nation who is also the CEO of a major cardiology practice. Under Dr. Martin's leadership as Medical Director of Heart and Vascular Services and Director of Surgical Quality, Anne Arundel Medical Center (AAMC) has become a nationally recognized facility for the treatment of vascular disease. Dr. Martin has made a formidable contribution to our nation's preventive healthcare movement and will draw from his extensive expertise to provide leadership and guidance for BioMedix™ company initiatives.

"BioMedix™ continues to make a difference with its innovative products—BioMedix™ technology offers a platform for providers to collaborate to find and treat more patients with vascular disease," said Dr. Martin, "I am excited to join an organization that has long been dedicated to promoting early detection and prevention of cardiovascular events."

Joining the Anne Arundel Medical Center medical staff in 1999, Dr. Martin has served on various hospital committees, including the Strategic Planning Committee of the Board of Trustees. Dr. Martin has developed training, education and multiple research initiatives for AAMC, as well as a dedicated vascular patient unit. In 2000, he co-founded the Dare to C.A.R.E. Foundation, a nonprofit organization dedicated to informing the community about the threat and treatment of cardiovascular disease, providing free cardiovascular screenings to more than 30,000 individuals to date.

"The clinical experience and knowledge of vascular health that Dr. Martin brings to BioMedix™ will strengthen our continuing mission of advancing technology-enabled collaborative care," said John Romans, BioMedix™ President and CEO. "We are very pleased to have a medical professional of his caliber join our team."

Dr. Martin received his BS from the University of Texas at San Antonio. He then completed medical school, his residency in surgery and a fellowship in peripheral vascular surgery at the University of Texas Southwestern Medical Center in Dallas. He is board certified in vascular surgery. In his new role, Dr. Martin will be overseeing care improvement initiatives, research agendas and medical policy development for BioMedix™ medical devices and collaborative care platforms.

About BioMedix™

BioMedix™ is a leader in Health Information Technology (HIT) software, products and services that connect Podiatric Physicians, Primary Care Physicians, vascular labs, vascular specialists, hospitals and healthcare systems in a continuum of collaborative care. We provide the only integrated suite of hardware, software and online services designed to cost-effectively detect vascular disease. Our award-winning suite of medical devices, advanced practice management and Electronic Health Record (EHR) software and web-based solutions give providers a more complete view of patient care. For more information about BioMedix™ products, call 877-854-0014 or log on to www.BioMedix.com.


'/>"/>
SOURCE BioMedix
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. BioMedix™ Now Exclusive Industry Distributor of the APMA Coding Resource Center
2. International Drug & Explosives Detection Company IDenta Corp. Announces New Representative in Japan
3. Neurocrine Biosciences Announces elagolix Scientific Presentations at the 11th World Congress on Endometriosis
4. American Medical Systems Announces Large-Scale, Physician-Led Registry of Penile Implants
5. Cordis Announces Discontinuation of NEVO™ Sirolimus-Eluting Coronary Stent
6. Endologix Announces FDA Approval of AFX™ Endovascular AAA System
7. Fuisz Announces Issuance of Patent Concerning Product Supplier Database Sharing With an On-Line Vendor
8. Generex Announces Appointment of CEO for Post-Spinout Antigen Express
9. Perrigo Announces Launch of the Generic Version of Nasacort® AQ
10. Masimo Announces Rainbow Agreement with Philips
11. Neurelis Announces Positive Results from Phase 1 Pharmacokinetic Study of NRL-01 (intranasal diazepam)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2017)... Medical Products, a leader in medical product innovation and global patient ... for hospice patient care. ... Centurion Medical Products ... pain management and emotional comfort are part of a hospice,s primary ... preventing unneeded emergency department admission due to severe fecal impaction. One ...
(Date:7/12/2017)... 12, 2017  Eli Lilly and Company (NYSE: ... companies to resolve pending patent litigation in the U.S. District ... regarding the Cialis ® (tadalafil) unit dose patent. ... 2020. As part of the agreement, Cialis exclusivity is now ... "The unit dose patent for Cialis is valid ...
(Date:7/11/2017)... , July 11, 2017  Sysmex America, Inc., ... diagnostic testing equipment as well as middleware information ... way to make quality assurance easier and more ... is well known for the innovation that it ... Monitor elevates quality assurance processes to a new ...
Breaking Medicine Technology:
(Date:7/24/2017)... ... July 24, 2017 , ... Horizon Goodwill ... a unique opportunity that helps high school girls succeed in STEM programs as ... Horizon Goodwill will host over 20 high school girls at their corporate ...
(Date:7/24/2017)... OH (PRWEB) , ... July 24, 2017 , ... The ... on the life-altering neurological condition called essential tremor (ET). The seminar will take place ... 5800 Rockside Woods Blvd., Independence, OH. The program will run from 9 a.m. to ...
(Date:7/24/2017)... , ... July 24, 2017 , ... ... media initiatives designed to promote awareness for Topricin’s revolutionary, natural, after-burn skin care ... one of the leading causes of long term skin conditions, including cancer. ...
(Date:7/24/2017)... ... July 24, 2017 , ... Puregraft, the ... announces the issuance of United States Patent Number 9,695,398 (the '398 patent) and ... The '398 and '324 patents cover methods and systems for optimizing fat ...
(Date:7/24/2017)... ... 2017 , ... Sharon Kleyne, host of the nationally syndicated The Sharon Kleyne ... Nature’s Tears® EyeMist® recently talked on the air about an alarming Post magazine article ... by Zidor Aldama described the situation in which Chinese children are under pressure to ...
Breaking Medicine News(10 mins):